A possible explanation for this finding is TET2 overexpression in cells of some aggressive and indolent NHL subtypes is an innate immune response, involving tumour suppressor and DNA repair pathways, to the specific subtype of malignancy. This evidence concerns the gene TET2 and non-Hodgkin lymphoma.